INGN
Inogen IncCompany Information
- Company Name
- Inogen Inc
- CIK
- CIK0001294133
- Category
- Accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- INGN: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3842
- SIC Description
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Ticker
- INGN
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-03-03
- Last sale
- 2026-07-01
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 21,708
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 17,755,391
- Shares outstanding
- 27,045,095
- Ownership
- 65.65%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -9.09%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 87 | 93 | 104 | 106 | 104 | 119 | 114 | 106 | 98 | 107 | 125 | 125 | ||||||
| Available For Sale Securities Debt Securities Current | 18 | 17 | 16 | 17 | 19 | - | 0 | 15 | 20 | 12 | 3 | 13 | ||||||
| Restricted Cash Current | 1 | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 4 | - | - | - | ||||||
| Accounts Receivable Net Current | 46 | 42 | 39 | 40 | 39 | 37 | 30 | 34 | 36 | 40 | 42 | 48 | ||||||
| Inventory Net | 29 | 25 | 26 | 25 | 24 | 26 | 25 | 23 | 24 | 25 | 22 | 24 | ||||||
| Income Tax Receivable | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 13 | 12 | 13 | 14 | 17 | 15 | 14 | 10 | 12 | 14 | 14 | 14 | ||||||
| Assets Current | 194 | 191 | 198 | 204 | 203 | 201 | 185 | 193 | 195 | 199 | 207 | 225 | ||||||
| Property Plant And Equipment Net | 32 | 34 | 36 | 37 | 40 | 41 | 44 | 47 | 47 | 49 | 50 | 50 | ||||||
| Goodwill | 10 | 10 | 11 | 11 | 11 | 10 | 9 | 10 | 10 | 10 | 10 | 10 | ||||||
| Finite Lived Intangible Assets Net | 27 | 29 | 31 | 32 | 33 | 32 | 30 | 34 | 34 | 33 | 35 | 34 | ||||||
| Operating Lease Right Of Use Asset | 15 | 16 | 17 | 17 | 18 | 18 | 18 | 19 | 20 | 21 | 20 | 21 | ||||||
| Other Assets Noncurrent | 7 | 6 | 6 | 6 | 7 | 7 | 8 | 4 | 4 | 4 | 4 | 4 | ||||||
| Assets | 286 | 286 | 299 | 307 | 312 | 308 | 296 | 306 | 309 | 316 | 326 | 344 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 40 | 33 | 34 | 34 | 35 | 36 | 27 | 27 | 27 | 32 | 30 | 30 | ||||||
| Employee Related Liabilities Current | 13 | 10 | 11 | 12 | 13 | 11 | 17 | 14 | 14 | 11 | 11 | 8 | ||||||
| Product Warranty Accrual Classified Current | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 9 | ||||||
| Operating Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | ||||||
| Accrued Income Taxes Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | 0 | ||||||
| Liabilities Current | 71 | 61 | 64 | 65 | 67 | 65 | 77 | 72 | 72 | 74 | 72 | 60 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Product Warranty Accrual Noncurrent | 18 | 18 | 18 | 18 | 17 | 16 | 16 | 16 | 16 | 15 | 14 | 13 | ||||||
| Operating Lease Liability Noncurrent | 13 | 13 | 14 | 15 | 16 | 16 | 17 | 17 | 18 | 19 | 18 | 19 | ||||||
| Contract With Customer Liability Noncurrent | 3 | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | 8 | 8 | 9 | ||||||
| Deferred Income Tax Liabilities Net | 6 | 7 | 7 | 8 | 8 | 7 | 7 | 8 | 8 | 8 | 9 | 8 | ||||||
| Liabilities | 111 | 103 | 106 | 110 | 113 | 110 | 122 | 121 | 121 | 124 | 121 | 113 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 360 | 363 | 364 | 362 | 360 | 357 | 328 | 327 | 325 | 323 | 321 | 322 | ||||||
| Retained Earnings Accumulated Deficit | -188 | -184 | -176 | -168 | -163 | -159 | -153 | -143 | -137 | -132 | -117 | -90 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 3 | 3 | 4 | 4 | 3 | -1 | -2 | 2 | -0 | 0 | 1 | -1 | ||||||
| Stockholders Equity | 175 | 183 | 192 | 197 | 199 | 198 | 174 | 185 | 188 | 192 | 205 | 231 | ||||||
| Liabilities And Stockholders Equity | 286 | 286 | 299 | 307 | 312 | 308 | 296 | 306 | 309 | 316 | 326 | 344 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 27 | 27 | 27 | 27 | 27 | 27 | 24 | 24 | 24 | 24 | 23 | 23 | ||||||
| Shares Outstanding | 27 | 27 | 27 | 27 | 27 | 27 | 24 | 24 | 24 | 24 | 23 | 23 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInogen Inc (INGN) — SEC Financial Statements & Analysis
Inogen Inc (INGN) is a orthopedic, prosthetic & surgical appliances & supplies company, incorporated in DE. Inogen Inc trades on Nasdaq as: INGN. Inogen Inc (INGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Inogen Inc carries a market cap of $174.44M, a P/E ratio of -7.09x, a P/B ratio of 1.00x, a P/S ratio of 0.49x, an enterprise value of $87.16M, and an EV/EBITDA multiple of -7.92x. On profitability, it posts a gross margin of 44.51%, an operating margin of -8.71%, a net margin of -6.94%, a Return on Equity (ROE) of -13.14%, a Return on Assets (ROA) of -8.23%, and a Return on Invested Capital (ROIC) of -30.57%. Per share, it reports EPS of $-0.91, diluted EPS of $-0.91, free cash flow per share of $-0.18, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 23.66% year-over-year, net income growth of -5.57% year-over-year, and EPS growth of -5.86% year-over-year. On the balance sheet, it maintains a current ratio of 2.74x, a quick ratio of 2.16x, working capital of $123.27M, a debt-to-equity ratio of 0.63x, a debt ratio of 0.39, free cash flow of $-4.98M (TTM), and net debt of $-87.28M. Figures sourced from SEC EDGAR.
- Market Cap
- $174.44M
- P/E TTM
- -7.09x
- EPS TTM
- $-0.91
- P/B TTM
- 1.00x
- ROE TTM
- -13.14%
- ROA TTM
- -8.23%
- Debt To Equity
- 0.63x
- Free Cash Flow TTM
- $-4.98M
- Net Revenue TTM Growth 1Y
- 23.66%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Inogen Inc in?
Inogen Inc (INGN) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry.
What exchange does INGN trade on?
Inogen Inc (INGN) trades on the Nasdaq.
Where is Inogen Inc incorporated?
Inogen Inc is incorporated in DE.
When was Inogen Inc (INGN)'s most recent SEC filing?
Inogen Inc (INGN)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is INGN's market cap?
Inogen Inc (INGN) has a market capitalization of $174.44M as of 2026-06-30.
What is INGN's EPS (earnings per share)?
Inogen Inc (INGN)'s trailing twelve month EPS is $-0.91 as of 2026-06-30.
What is INGN's ROE (return on equity)?
Inogen Inc (INGN)'s trailing twelve month Return on Equity (ROE) is -13.14% as of 2026-06-30.
What is INGN's ROA (return on assets)?
Inogen Inc (INGN)'s trailing twelve month Return on Assets (ROA) is -8.23% as of 2026-06-30.
What is INGN's ROIC (return on invested capital)?
Inogen Inc (INGN)'s trailing twelve month Return on Invested Capital (ROIC) is -30.57% as of 2026-06-30.
What is INGN's EV/EBITDA?
Inogen Inc (INGN)'s trailing twelve month EV/EBITDA is -7.92x as of 2026-06-30.